Plate IV.55 · Publications

Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers

Article in Cell Reports Medicine, January 2026.

Open accessResearch area: miRNA, Target, Cancer

Authors

  1. Julian Frädrich
  2. Carmen Mota Reyes
  3. Michel Hendel
  4. Vanessa Brunner
  5. Batu Toledo
  6. Damjan Manevski
  7. Alexander Sommer
  8. Daniel Häußler
  9. Dominik Beck
  10. Daniele Lucarelli
  11. Jaime Martínez de Villareal
  12. Lennard Halle
  13. Raphael Kfuri-Rubens
  14. Kaan Çifcibaşı
  15. Anna Hirschberger
  16. Rupert Öllinger
  17. Percy A. Knolle
  18. Katja Steiger
  19. Roland Rad
  20. Fabian J. Theis
  21. Francisco X. Real
  22. Stefanie Bärthel
  23. Jan P. Böttcher
  24. Dieter Saur
  25. Ihsan Ekin Demir
  26. Achim Krüger

Abstract

The immunosuppressive tumor microenvironment (TME) fosters cancer progression, yet overarching determinants of cancer-borne immunoinstruction remain ill-defined. By multimodal integration of single-nucleus and bulk transcriptomics, proteomics, functional approaches, and clinical parameters, we discover a cancer-immunoinstructive secretory signature (CISS) across multiple human cancers-a set of inflammatory proteins correlated with poor prognosis and pro-tumorigenic TMEs. In pancreatic cancer (PC), CISS arises in pre-malignant epithelium, intensifies along transformation toward most malignant basal-like PC, and particularly correlates with suppressed natural killer (NK) cell activity. The CISS is quantitatively dominated by tissue inhibitor of metalloproteinases (TIMP)-1, most prevalent in TIMP-1hi/CISShi basal-like PC, and causal for PC-cell-mediated NK cell suppression, reflected by impaired cytotoxicity, interleukin-2 (IL-2) responses, and mammalian target of rapamycin (mTOR) signaling. In pre-clinical PC, TIMP-1/CISS proves targetable through combined inhibition of upstream kinases with clinically approved drugs trametinib and nintedanib. Collectively, CISS represents a ubiquitous signature of pro-tumor immunoinstruction with actionable diagnostic and therapeutic potential across human cancers.

Cite

@article{fradrich2026multimodal,
  title = {{Multimodal profiling of pancreatic cancer reveals a TIMP-1-dominated secretory profile determining pro-tumor immunoinstruction in human cancers}},
  author = {Frädrich, Julian and Reyes, Carmen Mota and Hendel, Michel and Brunner, Vanessa and Toledo, Batu and Manevski, Damjan and Sommer, Alexander and Häußler, Daniel and Beck, Dominik and Lucarelli, Daniele and Martínez de Villareal, Jaime and Halle, Lennard and Kfuri-Rubens, Raphael and Çifcibaşı, Kaan and Hirschberger, Anna and Öllinger, Rupert and Knolle, Percy A. and Steiger, Katja and Rad, Roland and Theis, Fabian J. and Real, Francisco X. and Bärthel, Stefanie and Böttcher, Jan P. and Saur, Dieter and Demir, Ihsan Ekin and Krüger, Achim},
  journal = {Cell Reports Medicine},
  publisher = {Elsevier BV},
  year = {2026},
  month = jan,
  doi = {10.1016/j.xcrm.2025.102546},
  url = {https://doi.org/10.1016/j.xcrm.2025.102546},
  pmid = {41564862},
  pmcid = {PMC12866174}
}
.bib file